HUGE News and Press, FSD Pharma Inc. From 05/17/21

FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) is pleased to announce the results of its annual general and special meeting of the shareholders held on May 14 th , 2021 (the “ Meeting ”) at which...

FSD Pharma (HUGE) announced that the company filed a criminal complaint with the Financial Crimes Unit of Toronto Police against its former CFO Donal Carroll in relation to his alleged interference in the company’s banking relationships.“The complaint asserts that Mr. ...

Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - On Monday, May 10, 2021, at the request of Messrs. Anthony Durkacz and Zeeshan Saeed, founding shareholders and members of the group of concerned shareholders (the " Concerned Shareholders ") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE...

FSD Pharma (HUGE) announces that it has submitted an Investigational New Animal Drug Application ((IND)) to the U.S. FDA for the use of FSD201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat gastrointestinal enteropathy in dogs.The proposed trial design is a...

The FDA has accepted the Investigational new Animal Drug application for review The proposed trial is expected to be conducted at 5-10 sites in USA and will enroll up to 200 dogs Shareholders URGED to Vote the BLUE proxy by 9:00 a.m. on May 12, 2021 ...

Shareholders URGED to Vote the BLUE proxy by 9:00 a.m. on May 12, 2021 FSD Pharma Inc. (the “Company”) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent international corporate governance analysis and ...

FSD Pharma (HUGE) appoints Nathan Coyle, the company's corporate controller as its interim CFO, following the departure of Donal Carroll, effective immediately.Mr. Coyle joined FSD Pharma Inc in 2020 as Corporate Controller and has 15 years of executive business experience as a...

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the " Company " or " FSD Pharma ") is pleased to announce the appointment of Nathan Coyle, the Company's Corporate Controller as its Interim Chief Financial Officer, following the departure of Donal Carroll, effective immediately. ...

Toronto, Ontario--(Newsfile Corp. - April 26, 2021) - On Monday, April 26, 2021, the group of concerned shareholders (the " Concerned Shareholders ") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (the " Company " or " FSD ") filed and mailed an information circular and gold proxy t...

Management director nominees bring superior experience and expertise to drive positive growth, represent ALL shareholders interests and create value for ALL shareholders. FSD's COVID-19 FDA trials gaining momentum.  Management actively pursuing multi...